CHRIS GARABEDIAN

Profile

First Name

: CHRIS

Middle Name

:

Last Name

: GARABEDIAN

Related Companies
Titles
Company Name
Related People
DIRECTOR
QUELLIS BIOSCIENCES, INC.
FRED CALLORI, FREDERICK CALLORI, CHRISTOPHER GARABEDIAN, PETER HARWIN, TOMAS KISELAK, JONATHAN VIOLIN
DIRECTOR
VYOME THERAPEUTICS INC.
BHASKAR CHAUDHARI, KRISHNA GUPTA, MOHANJIT JOLLY, VENKATESWARLU NELABHOTLA, ALAB ROSLING, SHILADITYA SENGUPTA, KUMAR SHIRAIGI
DIRECTOR
CEREVASC, INC.
FREDERICK CALLORI, CARL HEILMAN, AARON LEVANGIE, DANIEL LEVANGIE, PATRICK SULLIVAN, LESLIE TESO-LICHTMAN
DIRECTOR
NEPHRODI THERAPEUTICS, INC.
FRED CALLORI, MICHAEL GRISSINGER, RACHAEL HAGAN, BIBHASH MUKHOPADHYAY, JEFF M. SANDS, M.D., DONNA SEE
DIRECTOR
FORGE BIOLOGICS HOLDINGS, LLC
MOLLY BONAKDARPOUR, FREDERICK CALLORI, CHRIS J. GARABEDIAN, MATTHEW HAMMOND, MOLLY J. MCCARTIN, TIMOTHY J. MILLER
DIRECTOR
SHIFA BIOMEDICAL CORP
TARIK S. ABDEL-MEGUID, SHERIN S. ABDEL-MEGUID, PH.D., GIANNA HOFFMAN-LUCA, SHAKER MOUSA
DIRECTOR
JUNO DIAGNOSTICS, INC.
FREDERICK CALLORI, JIM CHAUVAPUN, DIRK VAN DEN BOOM
DIRECTOR
TELLUS THERAPEUTICS, INC.
ERIC J. BENNER, FRED CALLORI, JASON E. KARLIC, JASON E. KRALIC, ALEX M. RUCKDAESCHEL
DIRECTOR
STREAM BIOMEDICAL, INC.
FRED CALLORI, AMANDA DE LA GARZA, WILLIAM SCHWIETERMAN
DIRECTOR
POLYCORE THERAPEUTICS, INC.
KELLY BECK, FREDERICK CALLORI, CHRISTOPHER CASHMAN, JAMES B. HARRIS
DIRECTOR
VIVOSENSE, INC.
COLIN BOWER, MARC CIKES, PETER FOSTER, DAVID HANKEY, RALF HEMPFLING, DOUGLAS MCALLISTER, LANCE MYERS, LANCE JONATHAN MYERS, DUDLEY TABAKIN
DIRECTOR
ASCLEPIX THERAPEUTICS, INC.
STEVEN ALTSCHULER, STEVEN ALTSCHULER, MD, BEN ASKEW, JOSH BARER, JOSHUA BARER, ROBERT DEMPSEY, JORDAN GREEN, JORDAN J. GREEN, NIRANJAN PANDEY, WENDY PERROW, ALEKSANDER POPEL, ALEKSANDER POPEL, PHD, ALEKSANDER S. POPEL, PHD, AMIR SHOJAEI, KEVIN SLAWIN, MD, SAPNA SRIVASTAVA, JILL TIERNEY
DIRECTOR
MAREA THERAPEUTICS, INC.
ANTOINE BOULANGER, JUNG CHOI, CHRISTINE GARRETT, MARK JOING, MAHA KATABI, JOSH LEHRER, TED LOVE, CAITLIN MURRAY, AARON ROYSTON, JEFF TONG, ETHAN WEISS
DIRECTOR
ZUCARA THERAPEUTICS INC.
FRED CALLORI, JANET GROVE, RICHARD LIGGINS, MICHAEL MARTIN, MICHAEL MIDMER, CLAUDE A PICHE
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-03-06
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2025-02-03 
2024-06-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-06-11 
2024-04-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-07-19 
2023-10-30
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2022-03-04 
2023-02-21
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-17 
2022-03-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-02-11 
2022-01-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-13 
2021-07-16
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-05-10 
2021-05-20
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2021-05-10 
2021-05-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-05-11 
2021-05-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-04-28 
2021-02-23
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-11 
2020-06-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-05-22 
2019-01-03
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-12-21 
2018-06-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-21